Revisiting Small Caps
Raina Oberoi / Ana Harris
April 14, 2021
As the world economy starts to feel the benefits of COVID-19 vaccines, some investors have started to revisit the role of small-cap stocks in their portfolios. Traditionally seen as riskier than mid- and large-cap stocks, small caps have historically been more sensitive to a benign economic backdrop.
Over the one-year period ended March 31, 2021, all major regional MSCI indexes underperformed their small-capitalization counterparts, with the exception of emerging markets. We saw the greatest outperformance in the U.S. where the MSCI USA Small Cap Index outperformed the MSCI USA Index by 35.8%. This strong performance of U.S. small caps comes on the back of a gradual re-opening of the economy and extensive vaccination program.
As of that same date, the MSCI’s adaptive multi-factor model showed a continued overweight of the low-size factor, as well as value.
If we take a longer view, as shown in the chart below, we find that on a five-year rolling basis, over the last 20 years, the small-cap regional indexes outperformed the large- and mid-cap indexes most of the time.1
Five-Year Rolling Excess Returns (%)
The chart shows the excess return of each regional small-cap index vs. its parent index.
Revisiting smallcap stocks - footnote
1Past performance — whether actual, backtested or simulated — is no indication or guarantee of future performance.